Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards Expands Peripheral Vascular Stent Pipeline With Orbus Deal

This article was originally published in The Gray Sheet

Executive Summary

Edwards Lifesciences' licensing agreement with Orbus Medical Technologies marks a decisive step toward enhancing its peripheral vascular disease treatments following the divestment phase of its reorganization strategy

You may also be interested in...



Edwards Sidesteps Crowded Coronary Stent Field, Targets Peripheral Stents

Edwards Lifesciences' vascular division will focus on peripheral stent technology development for the next few years, foregoing the significantly larger coronary stent market

Edwards Sidesteps Crowded Coronary Stent Field, Targets Peripheral Stents

Edwards Lifesciences' vascular division will focus on peripheral stent technology development for the next few years, foregoing the significantly larger coronary stent market

Edwards Pumps R&D Money Into Peripheral Stents Set To Launch In 2003

Edwards Lifesciences will hire 10-20 European sales representatives by 2003 to support the launch of a new line of peripheral stents

UsernamePublicRestriction

Register

OM005385

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel